Ultrasound Characterization of Disordered Antral Follicle Development in Women with Polycystic Ovary Syndrome.
Adolescent
Adult
Anovulation
/ blood
Anti-Mullerian Hormone
/ blood
Blood Glucose
Female
Humans
Insulin Resistance
/ physiology
Longitudinal Studies
Ovarian Follicle
/ diagnostic imaging
Polycystic Ovary Syndrome
/ blood
Progesterone
/ blood
Prospective Studies
Sex Hormone-Binding Globulin
/ metabolism
Testosterone
/ blood
Ultrasonography
Young Adult
anovulation
ovarian follicle
polycystic ovary syndrome
ultrasonography
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 11 2020
01 11 2020
Historique:
received:
13
02
2020
accepted:
06
08
2020
pubmed:
14
8
2020
medline:
17
2
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
The mechanism of oligo-anovulation in polycystic ovary syndrome (PCOS) is unknown. To evaluate follicular and endocrine characteristics of anovulatory and sporadic ovulatory cycles in women with PCOS. Prospective, longitudinal study. Academic clinical research unit. 26 reproductive-aged women (18-38 years) with PCOS, observed during natural anovulatory (PCOS-Anov; n = 12) and sporadic ovulatory cycles (PCOS-Ov; n = 14), and 12 controls. Transvaginal ultrasonography and venipuncture were performed every other day for 4 to 6 weeks in women with PCOS or at 1 interovulatory interval in control subjects. Follicle number and diameter (ie, ≥2 mm) were quantified at each visit. Individual growth profiles were assessed for all follicles that grew to ≥7 mm. Blood samples were assayed for follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone. Follicular excess, or heightened follicle number versus controls, was observed across anovulatory and sporadic ovulatory cycles in PCOS. In PCOS-Anov, follicles emerged cyclically in some women (6/12; 50%) and continuously in others (6/12; 50%), then grew to a mean maximum diameter of 7.2 mm and regressed within 4.7 days. In PCOS-Ov, follicles mostly emerged cyclically as part of a cohort and dominant follicles showed normal growth to ovulation-albeit mean and maximum luteal progesterone concentrations were significantly lower versus controls. Follicle growth and regression were detected on ultrasonography amidst perpetual follicular excess in PCOS. Documentation of continuous follicle recruitment and turnover, the absence of persistence, and altered luteal progesterone following sporadic ovulation, provide formative data on antral follicle development in PCOS.
Identifiants
pubmed: 32785651
pii: 5891761
doi: 10.1210/clinem/dgaa515
pmc: PMC7473602
pii:
doi:
Substances chimiques
Blood Glucose
0
Sex Hormone-Binding Globulin
0
Testosterone
3XMK78S47O
Progesterone
4G7DS2Q64Y
Anti-Mullerian Hormone
80497-65-0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : T32 DK007158
Pays : United States
Organisme : CIHR
ID : 146182
Pays : Canada
Informations de copyright
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Clin Endocrinol Metab. 2007 Jul;92(7):2468-73
pubmed: 17440019
Obes Rev. 2013 Feb;14(2):95-109
pubmed: 23114091
Hum Reprod Update. 2014 May-Jun;20(3):334-52
pubmed: 24345633
J Clin Endocrinol Metab. 1998 Nov;83(11):3984-91
pubmed: 9814480
Fertil Steril. 2009 Feb;91(2):440-9
pubmed: 18249401
Hum Reprod Update. 2008 Jul-Aug;14(4):367-78
pubmed: 18499708
Endocr Rev. 1995 Jun;16(3):322-53
pubmed: 7671850
J Obstet Gynecol Neonatal Nurs. 2006 May-Jun;35(3):376-84
pubmed: 16700687
Fertil Steril. 2010 Jun;94(1):184-8
pubmed: 19342014
Hum Reprod Update. 2006 Nov-Dec;12(6):673-83
pubmed: 16891296
Diabetes Care. 2004 Jun;27(6):1487-95
pubmed: 15161807
J Clin Endocrinol Metab. 2007 May;92(5):1975-8
pubmed: 17341570
Hum Reprod Update. 2004 Mar-Apr;10(2):107-17
pubmed: 15073141
Fertil Steril. 2003 Jul;80(1):116-22
pubmed: 12849812
J Clin Endocrinol Metab. 2015 Dec;100(12):4553-62
pubmed: 26465392
Ultrasound Med Biol. 2012 Jun;38(6):1004-10
pubmed: 22502889
Hum Reprod Update. 2003 Nov-Dec;9(6):505-14
pubmed: 14714587
Lancet. 2003 Sep 27;362(9389):1017-21
pubmed: 14522531
Menopause. 2013 Dec;20(12):1243-54
pubmed: 23571519
Ultrasound Obstet Gynecol. 2010 Dec;36(6):759-66
pubmed: 20645396
Ultrasound Med Biol. 2010 May;36(5):712-8
pubmed: 20381953
J Clin Endocrinol Metab. 2004 Nov;89(11):5321-7
pubmed: 15531477
Semin Reprod Med. 2008 Jan;26(1):53-61
pubmed: 18181083
Obstet Gynecol Surv. 1982 Feb;37(2):59-77
pubmed: 7033852
J Math Biol. 1997 Nov;36(1):95-118
pubmed: 9440305
J Endocrinol Invest. 1998 Oct;21(9):552-7
pubmed: 9856409
Hum Reprod. 2002 Jun;17(6):1459-63
pubmed: 12042261
Biol Reprod. 2003 Sep;69(3):1023-31
pubmed: 12748128
J Clin Endocrinol Metab. 1996 Jan;81(1):302-9
pubmed: 8550768
Fertil Steril. 2016 May;105(5):1322-1329.e1
pubmed: 26794423
J Clin Endocrinol Metab. 1994 Oct;79(4):1158-65
pubmed: 7962289
Hum Reprod Update. 2016 Nov;22(6):687-708
pubmed: 27511809
J Clin Endocrinol Metab. 2013 Dec;98(12):4565-92
pubmed: 24151290
Ultrasound Obstet Gynecol. 2005 May;25(5):498-507
pubmed: 15846762
J Reprod Fertil. 2000 Nov;120(2):361-6
pubmed: 11058451
Ultrasound Obstet Gynecol. 1994 Nov 1;4(6):488-93
pubmed: 12797130
J Clin Endocrinol Metab. 1994 Nov;79(5):1355-60
pubmed: 7962330
N Engl J Med. 2016 Feb 18;374(7):611-24
pubmed: 26886521
Hum Reprod Update. 2012 Jan-Feb;18(1):73-91
pubmed: 22068695
Hum Reprod Update. 2009 Jul-Aug;15(4):477-88
pubmed: 19279045
Hum Reprod. 2018 Sep 1;33(9):1602-1618
pubmed: 30052961
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012